Oğuzhan Kayhan

Oğuzhan Kayhan

Auto-generated profile, based on publicly available information

Oğuzhan Kayhan

Department of Anaesthesiology and Reanimation, İstanbul University-Cerrahpaşa, Cerrahpaşa School of Medicine, İstanbul, Turkey

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 February 2025 in Turkish Journal of Intensive Care
Verified
Journal Article
Open access
MKMünevver Kayhan
Münevver Kayhan
OKOğuzhan Kayhan
Oğuzhan Kayhan
YDYalim Dikmen
Yalim Dikmen
MÖMehmet Aykut Öztürk
Mehmet Aykut Öztürk
Amaç Bu çalışmada UpToDate ilaç etkileşimleri uygulaması ile potansiyel ilaç-ilaç etkileşimlerinin (PİİE) sıklığı ve kullanılan ilaç sayısının PİİE üzerindeki etkisinin araştırılması amaçlandı. Gereç ve Yöntem Çalışmaya 2016 yılında 3 gün ve daha fazla yoğun bakım ünitesinde tedavi gören 12 yaş üstü hastalar dahil edildi. 24 saatten fazla kullanılan ilaçların UpToDate uygulamasına girilmesiyle PİİE’ler tespit edildi. Hafif, orta ve ağır PİİE toplam sayısı ile kullanılan ilaç sayısı, kalış süresi, yaş, kronik hastalık sayısı, mekanik ventilasyon (MV) desteği, hastaneye yatış tanıları ve APACHE II skoru istatistiksel olarak karşılaştırıldı. Bulgular Uygulanan ilaç sayısı arttıkça PİİE’nin arttığı bulunurken, hastanede yatış gün sayısı ile kesin bir ilişki göstermediği belirlendi. Ancak MV desteği alan, APACHE II skoru yüksek olan ve ölen hastalarda bu oran daha yüksekti. PİİE en az postoperatif takip tanı grubunda görüldü. Sonuç Kritik hastalarda kullanılan ilaç sayısı arttıkça PİİE’nin arttığı belirlendi.

17 July 2019 in Turkish Journal of Anaesthesiology and Reanimation
Verified
Journal Article
Closed access
OKOguzhan Kayhan
Oguzhan Kayhan
EAEren Fatma Akcil
Eren Fatma Akcil
ODOzlem Korkmaz Dilmen
Ozlem Korkmaz Dilmen
YTYusuf Tunali
Yusuf Tunali
Effective pain management by avoiding side effects in the perioperative period is essential for patient outcome. Lumbar disc surgery is associated with moderate to severe postoperative pain, and opioids are widely used. The primary aim of the present study was to compare the effects of 1 mg and 2 mg morphine-impregnated absorbable cellulose haemostat material placed over the dura on morphine consumption, and the secondary aims were to compare pain scores and opioid-related side effects during postoperative 24 h. The study included 44 patients (American Society of Anesthesiologists I and II). After the discectomy procedure and before the closure, in Group A (n=15), 1 mg morphine-impregnated absorbable cellulose haemostat material placed over the dura was used. In Group B (n=14), 2 mg morphine was used for the same technique, and in Group C (n=15) (control), normal saline was used. All patients used intravenous morphine patient-controlled analgesia pumps for 24 h following lumbar disc surgery. Morphine consumption, pain scores and opioid-related side effects were recorded at 10 min, 1, 2, 6, 12 and 24 h postoperatively. Morphine consumption, pain scores and opioid-related side effects were similar among the groups. Morphine-impregnated absorbable cellulose haemostat material placement over the dura after single level lumbar discectomy did not reduce postoperative morphine consumption, pain scores and incidence of opioid-related side effects.

16 December 2019 in Cerrahpasa Medical Journal
Verified
Journal Article
Open access
HAHasan Aktaş
Hasan Aktaş
SBSuha Bozbay
Suha Bozbay
OKOğuzhan Kayhan
Oğuzhan Kayhan
ODOktay Demirkıran
Oktay Demirkıran
Objective: Nutritional support (NS) is an important part of the treatment of patients in the intensive care unit (ICU). The preferred method for NS is enteral nutrition (EN). The aim of the present study was to investigate the time of initiation of NS for patients admitted in the ICU, whether the nutritional target dose was achieved and if not, the factors that led to this. Methods: The study was planned retrospectively and included patients aged between 18 and 90 years, followed up between 01/01/2017 and 12/31/2018 in the emergency ICU. Patients’ demographic characteristics, the time of nutritional supplementation initiation, the time of achieving the target, and EN termination reasons during the nutritional status were evaluated. Results: A total of 152 patients were analyzed. Of the 152 patients, 49 were investigated for enteral feeding. Enteral NS was provided via nasogastric tube (93%) and percutaneous endoscopic gastrostomy (PEG) (7%). The mean time to start EN was 10.3 (±8.6) h. The mean time to reach the target was 14.1 (±5.9) h in 96% of the patients. In 2 patients, the target dose could not be reached due to vomiting and excess gastric residual volume. Thirty (61%) patients had problems during NS and EN interrupted. Conclusion: Any critically ill patient who has been in intensive care for >48 h should be considered at risk for malnutrition. In patients undergoing intensive care, it is recommended to start enteral feeding within 48 h (early enteral feeding) if there is no oral intake. Cite this article as: Aktaş H, Bozbay S, Kayhan O, Demirkıran O. Enteral Nutrition Target of Critical Patients in The Intensive Care Unit. Cerrahpasa Med J 2019; 43(3): 92-96.

1 October 2023 in Turkish Journal of Intensive Care
Verified
Journal Article
Closed access
GDGüvenç Doğan
Güvenç Doğan
OKOğuzhan Kayhan
Oğuzhan Kayhan
SKSelçuk Kayır
Selçuk Kayır
ODOktay Demirkıran
Oktay Demirkıran

25 August 2026 in Scientific Reports
Verified
Journal Article
Open access
PDF file
UKUmut Sabri Kasapoglu
Umut Sabri Kasapoglu
OMOzlem Yazicioglu Mocin
Ozlem Yazicioglu Mocin
ETEylem Tunçay
Eylem Tunçay
SGSinem Gungor
Sinem Gungor
HAHuseyin Arikan
Huseyin Arikan
ŞKŞerif Kurtuluş
Şerif Kurtuluş
Older patients now constitute a large proportion of ICU admissions, yet conventional severity scores may not adequately reflect their specific vulnerabilities. This study examined whether pre-ICU frailty, functional status, comorbidity burden and acute organ dysfunction at ICU admission were associated with 30-day all-cause mortality in patients aged ≥ 65 years, and whether the associations of geriatric vulnerability measures persisted in adjusted models that also included conventional physiology-based severity scores. In this multicentre prospective observational cohort study, 55 ICUs across 27 provinces in Türkiye enrolled consecutive eligible patients aged ≥ 65 years who had an ICU length of stay exceeding 48 h during a 1-month period. Pre-admission frailty and functional status were assessed using the Clinical Frailty Scale (CFS), FRAIL questionnaire and Katz Index of Activities of Daily Living (Katz ADL); comorbidity burden was assessed using the Charlson Comorbidity Index (CCI); and acute illness severity was assessed using the Sequential Organ Failure Assessment (SOFA), Acute Physiology and Chronic Health Evaluation II (APACHE II) and modified Nutrition Risk in the Critically Ill (mNUTRIC) scores. The primary outcome was 30-day all-cause mortality after ICU admission. Kaplan–Meier and Cox regression analyses were framed as conditional 48-h landmark analyses. Follow-up began at the 48-h landmark; observed death times were retained, and all patients alive at day 30 were administratively censored at landmark day 28. A total of 1,529 patients were included (median age, 77 years), and 30-day all-cause mortality was 33.7%. Frailty was common, with 71.2% of patients having a CFS ≥ 5. In the conventional primary Cox model, CFS (aHR 1.190 per one-point increase, 95% CI 1.129–1.255) and SOFA (aHR 1.182 per one-point increase, 95% CI 1.152–1.212) were associated with mortality. In the centre-clustered robust model, CFS (aHR 1.190, 95% CI 1.104–1.283) and SOFA (aHR 1.182, 95% CI 1.143–1.222) remained statistically significant, whereas CCI was estimated with less precision and was not statistically significant (aHR 1.034, 95% CI 0.989–1.081). The extended conventional and centre-clustered robust models including APACHE II yielded the same substantive pattern. Comparisons of organ-support therapies and ICU-acquired complications across vulnerability strata were descriptive and unadjusted. In this selected cohort of ICU patients aged 65 years or older with an ICU length of stay exceeding 48 h, pre-admission frailty and early organ dysfunction showed the most robust associations with 30-day all-cause mortality, whereas chronological age was not independently associated in the adjusted models. These findings should not be interpreted as evidence that chronological age is irrelevant, but rather that frailty and acute organ dysfunction remained associated with mortality after adjustment for chronological age in this cohort.

31 December 2020 in Infectious Diseases and Clinical Microbiology
Verified
Journal Article
Closed access
GAGokhan Aygun
Gokhan Aygun
OKOguzhan Kayhan
Oguzhan Kayhan
FHFatouma Moustapha Houssein
Fatouma Moustapha Houssein
SUSeval Urkmez
Seval Urkmez
AKAhmet Furkan Furkan Kurt
Ahmet Furkan Furkan Kurt
BMBilgul Mete
Bilgul Mete
Remdesivir is a novel nucleotide analogue antiviral drug with in vitro activity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (1). Food and Drug Administration (FDA) and Drug Controller General of India have authorized the emergency use for the treatment of COVID-19 under an